Susan Merenstein, Pharmacist/Owner

(412) 586-4678

Online Shop


Back to Products

$16.99

CBD Pain Balm Trial Size 40mg/gm NEW!!!

NEW!!!!  CBD Pain Balm Trial Size 40mg/mg

"I use CBD Pain Balm on my knees - when I don’t use it, I notice my knees and joints feels achy. Magnesium helps me sleep and stay on track. CBD Oil helps me sleep - 8 hours at night!"

- V. L.

A smooth and spreadable balm applied topically to painful areas like arthritic joints and painful damaged nerve areas. Massage in well as often as needed. Heat the area for a few minutes first for enhanced absorption.

  • No Detectable THC
  • No Detectable Solvents
  • No Detectable Pesticides
  • No Detectable Heavy Metals
  • Products are tested both internally and independently for potency, purity, and consistency.

Links to Certificates of Analysis:
Green Scientific - Certificate of Analysis 

Ingredients: Beeswax, CBD Broad Spectrum Hemp Oil 2000mg/50gr, Eucalyptus and Lavender essential oils  (0.0% THC),

Organically Farmed in accordance with Industrial Regulations (Reg. #69763) 

Hydrogenated Water and Supercritical CO2 Extraction Process – CO2 extraction allows the operator to tune the extraction using the process parameters (pressure, temperature, time, etc.) to extract specific compounds most efficiently. Ethanol extraction is less specific and will result in a lot of terpenes, waxes, and chlorophyll with your target compound.

ATTENTION: Some medications may interact or impact serving size. Please call 412-421-4996 or 412-586-4678 to speak to a Pharmacist about any medications you are taking.

Help us further CBD Research! Filling out our questionnaire will help us collect important data about CBD and your experience. Click here to fill out our CBD Questionnaire. Please call (412) 586-4678 if you would like further guidance.

Not recommended for use in pregnant women or women who are breastfeeding as there is not enough reliable information on these groups. Please consult your physician before use.

For more information on CBD please consult the following paper from the National Institutes of Health: PACHER P, BÁTKAI S, KUNOS G. The Endocannabinoid System as an Emerging Target of Pharmacotherapy. Pharmacological reviews. 2006;58(3):389-462. doi:10.1124/pr.58.3.2.

And the World Health Organization’s paper, “CANNABIDIOL (CBD) Pre-Review Report Agenda Item 5.2 Expert Committee on Drug Dependence, Thirty-ninth Meeting, Geneva, 6-10 November 2017.

Another useful resource is the National Institutes of Health’s US National Library of Medicine, https://medlineplus.gov/druginfo/natural/1439.html